Outcomes of triple-negative versus non-triple-negative breast cancers managed with breast-conserving therapy

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 6, 2014, Pages 2577-2581

  Bhatti, Abu Bakar Hafeez ^a   Khan, Amina Iqbal ^a   Siddiqui, Neelam ^a   Muzaffar, Nargis ^a   Syed, Aamir Ali ^a   Shah, Mazhar Ali ^a   Jamshed, Arif ^a  

^a SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL AND RESEARCH CENTRE   (Pakistan)

Author keywords

Breast conservative therapy; Outcome; Triple negative breast cancer

Indexed keywords

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; CANCER GRADING; CANCER STAGING; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; FOLLOW UP; HUMAN; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SEGMENTAL MASTECTOMY; SURVIVAL RATE; TRIPLE NEGATIVE BREAST NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRIPLE NEGATIVE BREAST NEOPLASMS; YOUNG ADULT;

EID: 84899865330     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.6.2577     Document Type: Article

References (31)

1. Abdulkarim BS, Cuartero J, Hanson J, et al (2011). Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modiied radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy. J Clin Oncol, 29, 2852-8.
2. Adami HO, Malker B, Holmberg L, et al (1986). The relation between survival and age at diagnosis in breast cancer. N Engl J Med, 315, 559-63.
3. Adkins FC, Gonzalez-Angulo AM, Lei X, et al (2011). Triple- negative breast cancer is not a contraindication for breast conservation. Ann Surg Oncol, 18, 3164-73.
4. Bauer KR, Brown M, Cress RD, et al (2007). Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer, 109, 1721-8.
5. Chu QD, Henderson AE, Ampil F, et al (2012). Outcome for patients with triple-negative breast cancer is not dependent on race/ethnicity. Int J Breast Cancer, 764570.
6. Chung M, Chang HR, Bland KI, et al (1996). Younger women with breast carcinoma have a poorer prognosis than older women. Cancer, 77, 97-103.
7. Dawood S, Broglio K, Kau SW, et al (2009). Triple receptor- negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes. J Clin Oncol, 27, 220-6.
8. Dent R, Trudeau M, Pritchard KI, et al (2007). Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res, 13, 4429-34.
9. Fisher B, Anderson S, Bryant J, et al (2002). Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med, 347, 1233-41.
10. Freedman GM, Anderson PR, Li T, et al (2009). Locoregional recurrence of triple-negative breast cancer after breast- conserving surgery and radiation. Cancer, 115, 946-51.
11. Haffty BG, Yang Q, Reiss M, et al (2006). Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol, 24, 5652-7.
12. Kwan ML, Kushi LH, Weltzien E, et al (2009). Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res, 11, 31.
13. Lowery AJ, Kell MR, Glynn RW, et al (2012). Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Res Treat, 133, 831-41.
14. Li CY, Zhang S, Zhang XB, et al (2013). Clinicopathological and prognostic characteristics of triple-negative breast cancer (TNBC) in Chinese patients: a retrospective study. Asian Pac J Cancer Prev, 14, 3779-84.
15. Ma KK, Chau WW, Wong CHN, et al (2012). Triple negative status is a poor prognostic indicator in Chinese women with breast cancer: a ten year review. Asian Pac J Cancer Prev, 13, 2109-14.
16. Mersin H, Yildirim E, Berberoglu U, et al (2008). The prognostic importance of triple negative breast carcinoma. Breast, 17, 341-6.
17. Millar EK, Graham PH, O'Toole SA, et al (2009). Prediction of local recurrence, distant metastases, and death after breast- conserving therapy in early-stage invasive breast cancer using a ive-biomarker panel. J Clin Oncol, 28, 4701-8.
18. Nguyen PL, Taghian AG, Katz MS, et al (2008). Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol, 26, 2373-8.
19. Nielsen TO, Hsu FD, Jensen K, et al (2004). Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res, 10, 5367-74.
20. O'Brien KM, Cole SR, Tse CK, et al (2010). Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res, 16, 6100-10.
21. Perou CM, Sorlie T, Eisen MB, et al (2000). Molecular portraits of human breast tumours. Nature, 406, 747-52.
22. Rakha EA, Reis-Filho JS, Ellis IO (2008). Basal-like breast cancer: a critical review. J Clin Oncol, 26, 2568-81.
23. Sharif MA, Mamoon N, Mushtaq S, et al (2010). Steroid hormone receptor association with prognostic markers in breast carcinoma in Northern Pakistan. J Coll Physicians Surg Pak, 20, 181-5.
24. Sidoni A, Cavaliere A, Bellezza G, et al (2003). Breast cancer in young women: clinicopathological features and biological speciicity. Breast, 12, 247-50.
25. Solin LJ, Hwang WT, Vapiwala N (2009). Outcome after breast conservation treatment with radiation for women with triple- negative early-stage invasive breast carcinoma. Clin Breast Cancer, 9, 96-100.
26. Sorlie T, Perou CM, Tibshirani R, et al (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA, 98, 10869-74.
27. Spitale A, Mazzola P, Soldini D, et al (2009). Breast cancer classiication according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Ann Oncol, 20, 628-35.
28. Van Dongen JA, Voogd AC, Fentiman IS, et al (2000). Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst, 92, 1143-50.
29. Voduc KD, Cheang MC, Tyldesley S, et al (2010). Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol, 28, 1684-91.
30. Wang J, Xie X, Wang X, et al (2013). Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer: a meta-analysis. Surg Oncol, 22, 247-55.
31. Zaky SS, Lund M, May KA, et al (2011). The negative effect of triple-negative breast cancer on outcome after breast- conserving therapy. Ann Surg Oncol, 18, 2858-65.